Nautilus Biotechnology, Inc. (NAUT) vs OnKure Therapeutics, Inc. (OKUR)

Nautilus Biotechnology, Inc. and OnKure Therapeutics, Inc. are both Biotechnology companies. Nautilus Biotechnology, Inc. and OnKure Therapeutics, Inc. are of similar size ($126.1M and $118.7M). Across the 9 metrics below, OnKure Therapeutics, Inc. leads on 6 and Nautilus Biotechnology, Inc. on 3.

Valuation

Metric NAUT OKUR Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 0.94 0.84 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.52 0.74
EV/Sales n/m n/m 10.73
Earnings yield (46.39%) (120.69%) (28.84%)
Free cash flow yield (42.05%) (33.10%) (23.03%)

Profitability

Metric NAUT OKUR Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (36.21%) (46.91%) (57.72%)
Return on assets (30.00%) (44.24%) (49.22%)
Return on invested capital (83.32%) 0.00% 0.00%

Growth

Metric NAUT OKUR Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 16.07% 71.20% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NAUT OKUR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.14 26.75 4.73
Net debt to EBITDA 1.67 0.95 0.96

Dividend

Metric NAUT OKUR Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric NAUT OKUR Biotechnology median
Market cap 126.05m 118.65m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack